Pfizer Inc. (PFE)
After hours:
| Previous Close | 44.08 |
| Open | 43.81 |
| Bid | 44.10 x 1200 |
| Ask | 44.11 x 1400 |
| Day's Range | 43.67 - 44.33 |
| 52 Week Range | 40.94 - 61.71 |
| Volume | |
| Avg. Volume | 17,705,993 |
| Market Cap | 246.012B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 25.68 |
| EPS (TTM) | 1.71 |
| Earnings Date | May 02, 2022 - May 06, 2022 |
| Forward Dividend & Yield | 1.60 (3.17%) |
| Ex-Dividend Date | Jul 28, 2022 |
| 1y Target Est | 58.49 |
- Zacks
Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why
Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.
- Baystreet
An Ideal ETF for Buy-and-Hold Investors
If you're looking for an investment that you can buy and hold for years, you'll probably want both some ...
- Reuters
UPDATE 1-Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11. The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the virus and the circulating BA.4 and BA.5 subvariants of Omicron.
